Literature DB >> 11406320

Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus.

J L Yau1, J Noble, C Hibberd, J R Seckl.   

Abstract

Chronic treatment with antidepressant drugs (2 weeks or longer) increases corticosteroid receptor mRNA expression in the hippocampus and reduces hypothalamic-pituitary-adrenal axis activity in parallel with improving mood and neuroendocrine function. Earlier effects are less well documented. We examined the effects of short term (9 days) treatment with fluoxetine (10 mg/kg) and venlafaxine (10 mg/kg) on hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) mRNA expression and spatial memory in adult rats. In situ hybridization histochemistry showed that the antidepressants decreased MR mRNA expression in all hippocampal subregions (e.g. 45% decrease in CA1 with venlafaxine, P<0.001), while GR mRNA expression was selectively reduced in the CA3 subregion. There was a trend for decreased plasma corticosterone levels following fluoxetine (50% fall, P=0.07) and venlafaxine (30% fall, P=0.18) but neither antidepressants affected spatial memory in the watermaze. Thus antidepressants can have complex and opposing actions on hippocampal corticosteroid receptor expression depending on the duration of treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406320     DOI: 10.1016/s0304-3940(01)01890-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine.

Authors:  Laurent Naudon; Maïté Hotte; Thérèse M Jay
Journal:  Psychopharmacology (Berl)       Date:  2007-01-12       Impact factor: 4.530

2.  Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.

Authors:  Georg Nikisch; Aleksander A Mathé; Adelheid Czernik; Jutta Thiele; Jürgen Bohner; Chin B Eap; Hans Agren; Pierre Baumann
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters.

Authors:  Carmine M Pariante; Richard B Kim; Andrew Makoff; Robert W Kerwin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

4.  Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers.

Authors:  Carmine M Pariante; Andrew S Papadopoulos; Lucia Poon; Anthony J Cleare; Stuart A Checkley; Judie English; Robert W Kerwin; Stafford Lightman
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

5.  Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.

Authors:  Elizabeth I Flandreau; Chase H Bourke; Kerry J Ressler; Wylie W Vale; Charles B Nemeroff; Michael J Owens
Journal:  Psychoneuroendocrinology       Date:  2012-12-23       Impact factor: 4.905

6.  Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.

Authors:  L A Carvalho; B A Garner; T Dew; H Fazakerley; C M Pariante
Journal:  Eur Neuropsychopharmacol       Date:  2010-03-15       Impact factor: 4.600

7.  Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor.

Authors:  C Anacker; P A Zunszain; A Cattaneo; L A Carvalho; M J Garabedian; S Thuret; J Price; C M Pariante
Journal:  Mol Psychiatry       Date:  2011-04-12       Impact factor: 15.992

Review 8.  Cortisol and Major Depressive Disorder-Translating Findings From Humans to Animal Models and Back.

Authors:  L Sanjay Nandam; Matthew Brazel; Mei Zhou; Dhanisha J Jhaveri
Journal:  Front Psychiatry       Date:  2020-01-22       Impact factor: 4.157

9.  Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist.

Authors:  Cristiane von Werne Baes; Camila Maria Severi Martins; Sandra Márcia de Carvalho Tofoli; Mário Francisco Juruena
Journal:  Front Psychiatry       Date:  2014-01-24       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.